Allele limits its sector, investment and capital sourcing focus to ensure a successful collaboration for both our corporate and investment partners. In addition to extensive corporate and scientific due diligence, Allele focuses on two major themes: Alpha and Access.
Alpha: We work to provide our accredited and institutional investors with the potential for above-average returns who are willing to accept above-average risk in private-to-public and small-cap public investments in life science companies. We focus on companies that can achieve initial investor liquidity, proof of concept (POC), successful milestones and/or valuation inflection points within a 12 to 24-month time period.
Access: We partner with executive leaders demonstrating exceptional results (ELDERs™) to provide value-added advice by leveraging our extensive network of C-suite level relationships, key opinion leaders (KOLs) and access to both accredited and institutional capital.